HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Murad Sun Care Pomegranate Ingredient Increases SPF Level 21% - Firm

This article was originally published in The Rose Sheet

Executive Summary

Murad's Daily Defense anti-aging sun care line is based on pomegranate extract, an antioxidant that increases the products' SPF level by as much as 21%, the El Segundo, Calif.-based company claims.

You may also be interested in...



Murad Therapy Addresses Rosacea-Like Redness With Goji Berry Extract

Murad Redness Therapy is one of the first skin care regimens in the salon and spa markets designed specifically to treat skin redness, according to CEO and founder Howard Murad

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007822

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel